BeiGene Ebit vs Minority Interest Analysis

BGNE Stock

USD 161.48 0.71 0.44%

BeiGene financial indicator trend analysis is way more than just evaluating BeiGene prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BeiGene is a good investment. Please check the relationship between BeiGene Ebit and its Minority Interest accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.

Ebit vs Minority Interest

Ebit vs Minority Interest Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BeiGene Ebit account and Minority Interest. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between BeiGene's Ebit and Minority Interest is 0.46. Overlapping area represents the amount of variation of Ebit that can explain the historical movement of Minority Interest in the same time period over historical financial statements of BeiGene, assuming nothing else is changed. The correlation between historical values of BeiGene's Ebit and Minority Interest is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit of BeiGene are associated (or correlated) with its Minority Interest. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Minority Interest has no effect on the direction of Ebit i.e., BeiGene's Ebit and Minority Interest go up and down completely randomly.

Correlation Coefficient

0.46

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Ebit

Minority Interest

Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of BeiGene whose combined shares represent less than 50% of the total outstanding shares issued by BeiGene have a minority interest in BeiGene.

Most indicators from BeiGene's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BeiGene current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.At present, BeiGene's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 17.4 B, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.84.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	990.9M	1.3B	3.2B	3.4B
Cost Of Revenue	1.6B	1.9B	463.9M	755.2M

Total Operating Expenses Cost Of Revenue

BeiGene fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross
Total Assets		0.86	0.61	0.85	1.0	0.95	0.94	0.71	0.68	-0.92	-0.82	0.88	0.92	0.77	-0.3	0.65	0.77	0.99	0.87	0.9	0.65	0.94	0.93	0.9	0.92	0.71
Short Long Term Debt Total	0.86		0.84	0.96	0.83	0.86	0.95	0.96	0.41	-0.89	-0.99	0.99	0.94	0.96	-0.45	0.32	0.73	0.8	0.96	0.89	0.32	0.83	0.96	0.99	0.97	0.96
Other Current Liab	0.61	0.84		0.92	0.58	0.7	0.82	0.94	0.1	-0.71	-0.85	0.82	0.77	0.95	-0.05	0.29	0.52	0.54	0.81	0.64	0.05	0.45	0.82	0.82	0.82	0.92
Total Current Liabilities	0.85	0.96	0.92		0.83	0.91	0.97	0.95	0.38	-0.88	-0.95	0.96	0.92	0.98	-0.22	0.42	0.65	0.8	0.93	0.84	0.36	0.73	0.95	0.97	0.97	0.94
Total Stockholder Equity	1.0	0.83	0.58	0.83		0.95	0.93	0.68	0.7	-0.92	-0.79	0.87	0.91	0.74	-0.28	0.68	0.76	0.99	0.85	0.88	0.68	0.94	0.92	0.89	0.91	0.68
Other Liab	0.95	0.86	0.7	0.91	0.95		0.96	0.75	0.64	-0.87	-0.82	0.89	0.89	0.81	-0.14	0.63	0.68	0.95	0.87	0.84	0.69	0.86	0.92	0.9	0.94	0.73
Net Tangible Assets	0.94	0.95	0.82	0.97	0.93	0.96		0.88	0.52	-0.94	-0.93	0.96	0.96	0.92	-0.27	0.55	0.73	0.92	0.95	0.88	0.5	0.86	0.99	0.98	0.99	0.87
Property Plant And Equipment Net	0.71	0.96	0.94	0.95	0.68	0.75	0.88		0.2	-0.8	-0.97	0.93	0.87	0.99	-0.36	0.19	0.62	0.64	0.91	0.79	0.1	0.64	0.89	0.93	0.91	1.0
Current Deferred Revenue	0.68	0.41	0.1	0.38	0.7	0.64	0.52	0.2		-0.51	-0.36	0.48	0.49	0.29	-0.13	0.58	0.66	0.73	0.48	0.54	0.74	0.76	0.54	0.47	0.51	0.2
Net Debt	-0.92	-0.89	-0.71	-0.88	-0.92	-0.87	-0.94	-0.8	-0.51		0.88	-0.88	-0.99	-0.83	0.44	-0.67	-0.65	-0.89	-0.85	-0.87	-0.37	-0.87	-0.94	-0.94	-0.92	-0.82
Retained Earnings	-0.82	-0.99	-0.85	-0.95	-0.79	-0.82	-0.93	-0.97	-0.36	0.88		-0.97	-0.93	-0.96	0.49	-0.28	-0.68	-0.76	-0.93	-0.88	-0.22	-0.78	-0.94	-0.98	-0.95	-0.98
Accounts Payable	0.88	0.99	0.82	0.96	0.87	0.89	0.96	0.93	0.48	-0.88	-0.97		0.93	0.95	-0.38	0.35	0.8	0.84	0.98	0.88	0.41	0.86	0.98	0.99	0.98	0.93
Cash	0.92	0.94	0.77	0.92	0.91	0.89	0.96	0.87	0.49	-0.99	-0.93	0.93		0.89	-0.45	0.59	0.68	0.88	0.9	0.88	0.35	0.87	0.97	0.97	0.96	0.88
Non Current Assets Total	0.77	0.96	0.95	0.98	0.74	0.81	0.92	0.99	0.29	-0.83	-0.96	0.95	0.89		-0.27	0.29	0.67	0.7	0.93	0.8	0.21	0.67	0.93	0.95	0.94	0.98
Non Currrent Assets Other	-0.3	-0.45	-0.05	-0.22	-0.28	-0.14	-0.27	-0.36	-0.13	0.44	0.49	-0.38	-0.45	-0.27		0.11	-0.2	-0.25	-0.3	-0.49	0.18	-0.49	-0.31	-0.42	-0.32	-0.43
Other Assets	0.65	0.32	0.29	0.42	0.68	0.63	0.55	0.19	0.58	-0.67	-0.28	0.35	0.59	0.29	0.11		0.32	0.69	0.34	0.41	0.5	0.52	0.53	0.43	0.48	0.2
Long Term Debt	0.77	0.73	0.52	0.65	0.76	0.68	0.73	0.62	0.66	-0.65	-0.68	0.8	0.68	0.67	-0.2	0.32		0.74	0.83	0.7	0.51	0.82	0.8	0.73	0.72	0.6
Cash And Short Term Investments	0.99	0.8	0.54	0.8	0.99	0.95	0.92	0.64	0.73	-0.89	-0.76	0.84	0.88	0.7	-0.25	0.69	0.74		0.83	0.85	0.74	0.94	0.89	0.86	0.89	0.63
Common Stock Total Equity	0.87	0.96	0.81	0.93	0.85	0.87	0.95	0.91	0.48	-0.85	-0.93	0.98	0.9	0.93	-0.3	0.34	0.83	0.83		0.83	0.43	0.83	0.96	0.96	0.96	0.89
Common Stock Shares Outstanding	0.9	0.89	0.64	0.84	0.88	0.84	0.88	0.79	0.54	-0.87	-0.88	0.88	0.88	0.8	-0.49	0.41	0.7	0.85	0.83		0.42	0.87	0.87	0.9	0.88	0.8
Short Term Investments	0.65	0.32	0.05	0.36	0.68	0.69	0.5	0.1	0.74	-0.37	-0.22	0.41	0.35	0.21	0.18	0.5	0.51	0.74	0.43	0.42		0.63	0.45	0.38	0.46	0.07
Non Current Liabilities Total	0.94	0.83	0.45	0.73	0.94	0.86	0.86	0.64	0.76	-0.87	-0.78	0.86	0.87	0.67	-0.49	0.52	0.82	0.94	0.83	0.87	0.63		0.87	0.86	0.85	0.65
Other Current Assets	0.93	0.96	0.82	0.95	0.92	0.92	0.99	0.89	0.54	-0.94	-0.94	0.98	0.97	0.93	-0.31	0.53	0.8	0.89	0.96	0.87	0.45	0.87		0.98	0.98	0.89
Other Stockholder Equity	0.9	0.99	0.82	0.97	0.89	0.9	0.98	0.93	0.47	-0.94	-0.98	0.99	0.97	0.95	-0.42	0.43	0.73	0.86	0.96	0.9	0.38	0.86	0.98		0.99	0.94
Total Liab	0.92	0.97	0.82	0.97	0.91	0.94	0.99	0.91	0.51	-0.92	-0.95	0.98	0.96	0.94	-0.32	0.48	0.72	0.89	0.96	0.88	0.46	0.85	0.98	0.99		0.9
Property Plant And Equipment Gross	0.71	0.96	0.92	0.94	0.68	0.73	0.87	1.0	0.2	-0.82	-0.98	0.93	0.88	0.98	-0.43	0.2	0.6	0.63	0.89	0.8	0.07	0.65	0.89	0.94	0.9

Click cells to compare fundamentals

BeiGene Account Relationship Matchups

BeiGene fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.6B	5.6B	8.6B	6.4B	5.8B	3.2B
Short Long Term Debt Total	277.3M	562.0M	694.6M	891.1M	930.2M	976.7M
Other Current Liab	152.7M	127.8M	480.0M	114.3M	784.4M	823.6M
Total Current Liabilities	286.0M	1.1B	1.6B	1.0B	1.8B	1.9B
Total Stockholder Equity	978.4M	3.9B	6.2B	4.4B	3.5B	2.2B
Other Liab	57.1M	443.3M	562.5M	283.7M	326.3M	342.6M
Net Tangible Assets	956.3M	3.9B	6.2B	4.3B	5.0B	5.2B
Property Plant And Equipment Net	313.1M	446.3M	686.7M	845.9M	1.4B	1.5B
Net Debt	(340.7M)	(820.0M)	(3.7B)	(3.0B)	(2.3B)	(2.1B)
Retained Earnings	(2.0B)	(3.6B)	(5.0B)	(7.1B)	(8.0B)	(7.6B)
Accounts Payable	122.5M	232.0M	262.4M	294.8M	315.1M	330.9M
Cash	618.0M	1.4B	4.4B	3.9B	3.2B	3.3B
Non Current Assets Total	439.6M	640.1M	1.0B	845.9M	1.6B	1.7B
Non Currrent Assets Other	2.5M	24.6M	30.7M	(186.5M)	(18.7M)	(17.8M)
Other Assets	108.7M	186.8M	8.6B	819.9M	2.0	1.9
Long Term Debt	240.7M	183.6M	202.1M	209.1M	197.6M	143.1M
Cash And Short Term Investments	985.5M	4.7B	6.6B	4.5B	3.2B	2.3B
Common Stock Total Equity	77K	79K	118K	133K	153.0K	160.6K
Common Stock Shares Outstanding	60.1M	83.5M	92.8M	103.1M	104.4M	72.1M
Short Term Investments	364.7M	3.3B	2.2B	665.3M	2.6M	2.5M
Liabilities And Stockholders Equity	1.6B	5.6B	8.6B	6.4B	5.8B	3.2B
Non Current Liabilities Total	347.9M	656.3M	803.4M	977.9M	423.6M	372.9M
Other Current Assets	85.8M	133.0M	246.2M	190.9M	205.5M	215.8M
Other Stockholder Equity	2.9B	7.4B	11.2B	11.5B	11.6B	12.2B
Total Liab	633.9M	1.7B	2.4B	2.0B	2.2B	2.3B
Property Plant And Equipment Gross	324.9M	399.5M	811.0M	1.1B	1.6B	1.7B
Total Current Assets	1.2B	5.0B	7.6B	4.7B	4.2B	2.6B
Accumulated Other Comprehensive Income	(8.0M)	6.9M	18.0M	(77.4M)	(99.4M)	(94.5M)
Short Term Debt	10.8M	348.9M	449.5M	353.0M	710.3M	745.8M
Common Stock	79K	118K	133K	135K	155.3K	83.2K
Property Plant Equipment	324.9M	357.7M	587.6M	955.9M	1.1B	1.2B
Deferred Long Term Liab	11.1M	10.5M	10.8M	14.2M	16.3M	10.1M
Long Term Debt Total	189.7M	240.7M	183.6M	202.1M	232.4M	156.4M
Capital Surpluse	2.7B	2.9B	7.4B	11.2B	12.9B	13.5B
Net Receivables	72.8M	79.7M	500.2M	173.2M	395.9M	415.7M
Retained Earnings Total Equity	(1.0B)	(2.0B)	(3.6B)	(5.0B)	(4.5B)	(4.2B)
Inventory	28.6M	89.3M	242.6M	282.3M	416.1M	436.9M

Pair Trading with BeiGene

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BeiGene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BeiGene will appreciate offsetting losses from the drop in the long position's value.

The ability to find closely correlated positions to BeiGene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BeiGene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BeiGene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BeiGene to buy it.

The correlation of BeiGene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BeiGene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BeiGene moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for BeiGene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports:

How To Invest In BeiGene

Details

Is BeiGene Stock a good investment?

Details

What is BeiGene's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.

You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for BeiGene Stock analysis

When running BeiGene's price analysis, check to measure BeiGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeiGene is operating at the current time. Most of BeiGene's value examination focuses on studying past and present price action to predict the probability of BeiGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeiGene's price. Additionally, you may evaluate how the addition of BeiGene to your portfolios can decrease your overall portfolio volatility.

	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals

Is BeiGene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(7.54)

Revenue Per Share

26.458

Quarterly Revenue Growth

0.679

Return On Assets

(0.12)

Return On Equity

(0.21)

The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BeiGene Ebit vs Minority Interest Analysis

Ebit vs Minority Interest

Ebit vs Minority Interest Correlation Analysis

Correlation Coefficient

Ebit

Minority Interest

BeiGene fundamental ratios Correlations

BeiGene Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BeiGene fundamental ratios Accounts

Pair Trading with BeiGene

Complementary Tools for BeiGene Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 0.99	Total Assets
Accounts Payable	+ 0.99	Short Long Term Debt Total
Other Stockholder Equity	+ 0.99	Short Long Term Debt Total
Cash And Short Term Investments	+ 0.99	Total Stockholder Equity

Cash	- 0.99	Net Debt
Retained Earnings	- 0.99	Short Long Term Debt Total
Property Plant And Equipment Gross	- 0.98	Retained Earnings
Other Stockholder Equity	- 0.98	Retained Earnings
Accounts Payable	- 0.97	Retained Earnings
Retained Earnings	- 0.97	Property Plant And Equipment Net